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The primary cilium is an organelle acting as a master regulator of cellular signalling. We have previously shown
that disruption of primary cilia assembly, through targeting intraflagellar transport, is associated with muted
nitric oxide and prostaglandin responses to the inflammatory cytokine interleukin-1β (IL-1β). Here, we show
that loss of the primary cilium disrupts specific molecular signalling events in cytosolic NFκB signalling. The
induction of cyclooxygenase 2 (COX2) and inducible nitrous oxide synthase (iNOS) protein is abolished. Cells
unable to assemble cilia exhibit unaffected activation of IκB kinase (IKK), but delayed and reduced degradation
of IκB, due to diminished phosphorylation of inhibitor of kappa B (IκB) by IKK. This results in both delayed and
reduced NFκB p65 nuclear translocation and nuclear transcript binding. We also demonstrate that heat shock
protein 27 (hsp27), an established regulator of IKK, is localized to the ciliary axoneme and cellular levels are
dramatically disruptedwith loss of the primary cilium. These results suggest that the primary cilia compartment
exerts influence over NFκB signalling. We propose that the cilium is a locality for regulation of the molecular
events defining NFκB signalling events, tuning signalling as appropriate.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Primary cilia influence a wide variety of cell signalling pathways
linked to development, health and disease. These include
established functions for primary cilia in left–right determination
[1], mechanosensation [2,3], defined roles in the regulation of
hedgehog (Hh) [4,5], platelet derived growth factor (PDGF) signalling
[6], and more recently, wnt [7–10], insulin growth factor (IGF) [11],
and transforming growth factor (TGF) [12] signalling. The early hypoth-
eses and interpretations were that the cilium acted as an antenna for
signal detection, which, in many contexts, has proven to be the case.
Increasingly, however, research indicates that the specialized ciliary
compartment often influences signal transduction, downstream of
the reception of an initial stimulus but upstream of transcriptional
responses. Thismay tune not only themagnitude of signalling, as exem-
plified by roles in hedgehog and wnt where transcriptional activity can
be both promoted and dampened [10,13], but also the temporal charac-
teristics of signalling as exemplified by IGF receptor sensitization [11].
In doing so the cilium encodes the necessary additional complexity
where one stimulus activates a plethora of targets.
Much of our understanding of primary cilia biology, including these
examples, comes from studying the effect ofmutations to genes encoding
the cilium's specialized trafficking machinery. This machinery includes
proteins that function in intraflagellar transport (IFT) which is responsi-
ble for anterograde and retrograde molecular trafficking up and down
ciliarymicrotubules. Mutations in proteins thought to support these pro-
cesses are the source of a growing number of human pathologies known
collectively as ciliopathies. In 2012 we used a hypomorphic mutation of
the gene tg737, encoding for polaris or IFT88, to understand the relevance
of primary cilia elongation in response to the inflammatory cytokine
interleukin-1β [14]. Cilia length change is a function of altered ciliary
trafficking and contents and as such indicative of potential alterations
to cilia function for example in wnt [15], hedgehog signalling [16] and
mechanotransduction [17] contexts. However, a function for the cilium
in IL-1β signalling was previously unheralded. Near complete loss of
the ciliary compartment, as a result of this mutation or pharmacological
blockade of cilia elongation, yielded a diminished response at the level
of nitrite release and prostaglandin E2 release [14]. These inflammatory
second messengers are the products of inducible nitrous oxide synthase
(iNOS) and a cascade of phospholipid metabolism steps culminating
with stimulation of the rate limiting enzyme cyclooxygenase 2 (COX2)
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and ultimately prostaglandin E synthases (PGES). The purpose of the
present study was to unravel the mechanism that accounts for the
loss of this inflammatory response when the ciliary trafficking is
compromised.
Interleukin-1β activates a wide range of intracellular signalling
leading to induction of many alterations in cellular activity. To a large
extent IL-1β pro-inflammatory activities are modulated by either
NFκB signalling, or mitogen activated kinase (MAP) activities [18] or
combinations of both. NFκB signalling components are well-
conserved, activated in response to a plethora of stimuli and regulate
and/or are entwined inmany cellular processes. These include immuni-
ty and differentiation amongmany others. For a recent review see [19].
A rapid cascade of protein–protein interactions defines the pathway.
Phosphorylations, SUMOlyations and ubiquitinations, both positively
and negatively regulate signalling. Two such events are at the heart of
pro-inflammatory signalling, namely inhibitor of kappa kinase (IKK)
mediated phosphorylation [20] of the protein inhibitor of NFκB (IκB)
[21] and the subsequent proteosomal destruction of IκB following
ubiquitination by FWD1 [22]. This allows NFκB transcription factor sub-
units to be released to the nucleus [23,24] where they activate or co-
activate many targets including iNOS and COX2 [25–28]. This key se-
quence of events is preceded by receptor-linked events including
the molecular binding between and activations of interleukin receptor
associated kinases (IRAKs), tumour necrosis factor (TNF) receptor
associated factor 6 (TRAF6), and transforming growth factor activated
kinase 1 (TAK1). TAK1 is ultimately responsible for IKK activation
through phosphorylation of the IKK complex regulatory subunit NEMO
[29]. Complex formation between these upstream effectors, namely
IRAK1 and TRAF6 and TAK1 and NEMO, facilitates pathway activation
[30]. Heat shock proteins (HSP) are known to both facilitate and control
many of the cascade of molecular interactions throughout signal trans-
duction. One such HSP is the chaperone Hsp27, proposed to regulate
TRAF, TAK, JNK, p38 and IKK activities [31–36].
2. Materials and methods
2.1. Cell culture
The current study used murine cells harbouring a hypomorphic
mutation in TG737 encoding for IFT88 as described previously [14,37].
Once removed from conditional immortalization these cells have a
primary chondrocyte phenotype [37]. Chondrocytes are an apt model
for this project as they express high prevalence of primary cilia expressed
relatively parallel to culture surface on the basal lateral surface, an ad-
vantage for confocal imaging. In addition there is biological relevance
as interleukin-1β is found elevated in the joints during many forms
of arthritis [38] as are the inflammatory chemokines PGE2 and NO
[39–41]. The cell line was cultured in low glucose DMEM supplemented
with 10% foetal calf serum, 88 UmL−1 penicillin, 90 μg·mL streptomycin
and 2.5 mM L-glutamine. Immortalization, under permissive conditions
of 33 °C culture and in the presence of 10 ng·mL−1 Interferon-γ (INF)
(R&D systems, UK), was used only for maintenance of the line. For all
experiments cells were cultured at 37 °C without INF for 3 days, as has
previously been shown to be sufficient to switch off SV40 expression,
before use as primary cells. For protein expression studies cells were cul-
tured on plastic, and for immunofluorescence studies cells were cultured
on FCS coated glass coverslips.
2.2. Protein isolation
For total cell protein isolations cell lysates were collected quickly
on ice. Plastic culture wells were washed once in ice cold phosphate
buffered saline (PBS) with 50 μM sodium orthovanadate. Subsequently
an ice cold lysis buffer of PBS, a cocktail of protease inhibitors (Roche),
50 μM sodium orthovanadate (Sigma) and 0.1% Igebal (Sigma) was
added and samples were left on ice for 15 min before scraping and
5 homogenization steps, through a 21 G needle. Samples were then
spun at 13,000 RPM for 15 min at 4 °C before supernatant was frozen
in liquid nitrogen, stored at−80 °C. Where required nuclear and cyto-
plasmic fractions were collected using a protocol based on an isolation
kit (EpiSeeker extraction kit ab113474, Abcam, UK). In short, after a
gentle initial lysis protocol the cytoplasmic fraction was removed and
a buffer containing dithiothreitol or DTT was added to the leftover
nuclear pellet to create a highly concentrated nuclear fraction lysate
whichwas incubated on ice for 15minwith vortexing before refrigerated
centrifugation and storage at−80 °C.
2.3. Western blotting
For western blotting lysate samples were diluted 1:1 with Laemmli
buffer then boiled at 100 °C for 5 min. For total protein studies samples
of around 30 μL, or 50 μg protein as assessed by the Bradford assay, were
run on a 10 or 12% tris(hydroxymethyl)aminomethane–hydrochloride
gels before transfer to a nitrocellulose membrane. Nuclear fraction
lysates were more concentrated and only 10 μL volume was required
but again evenly loaded following Bradford analysis. Transfers and load-
ing were checked using ponceau staining. 1 h in 5% milk or 3–5% BSA
(for blocking) preceded primary antibody incubations overnight at
4 °C. Licor infrared secondary antibodies were incubated at 1:15,000
(anti-mouse and anti-goat) or 1:7500 (anti-rabbit) for 1 h at room tem-
perature preceded and followed by 3 × 10 min washes in 0.1% PBS
Tween. Relative protein expression was established by quantitative
analysis of specific bands (LI-COR Odyssey integrated intensity values).
Linearity ofwestern blots analysiswas tested by constructing a standard
curve using serial dilutions of samples probed for β-tubulin. Relative ex-
pression was quantified relative to β-actin, β-tubulin or lamin C. Anti-
bodies used were: Rabbit mAb to COX2 1:1000 (Cell Signaling 12282),
Rabbit pAb to iNOS 1:500 (Abcam ab3523), Rabbit pAb to NFκB p65
1:1000 (Abcam ab7970), Rabbit mAb to phospho IKK ser176/180
1:500 (Cell Signaling 2697), Mouse mAb to phospho IκBα ser32/36
1:500 (Cell Signaling 9246), Rabbit mAb to IκBα 1:10,000 (Abcam
ab32518), Mouse aAb to β-actin 1:10,000 (Abcam ab8226), Goat pAb
to lamin A/C 1:2000 (Santa Cruz sc-6215), Mouse mAb to β-tubulin
1:5000 (Sigma T4026), Goat pAb to hsp27 (Santa Cruz SC-1048), and
Rabbit mAb to phsp27 ser82 1:1000 (Cell Signaling 9709).
2.4. NFκB p65 binding ELISA
Nuclear lysates were assessed to quantify relative nuclear p65 tran-
script bindingwith a kit (ab133128) fromAbcam, UK. In short, a specific
double stranded DNA sequence containing the NFκB response element
is immobilized onto the wells of a 96 well plate for ELISA analysis of
p65 binding as detected by antibody binding and HRP conjugate detec-
tion. Both positive and non-specific binding controls were included. Ab-
sorbance was measured at 450 nm. Results were normalized to lamin
C expression.
2.5. Immunofluorescent staining and imaging
Samples prepared for immunofluorescent labelling were fixed for
7 min at 37 °C in 4% paraformaldehyde. Glass coverslips were treated
with 0.5% triton for 5 min and blocked with 5% goat serum for 30 min.
Primary incubations of either 1:500 Rabbit anti-NFκB p65, 1:2000
mouse anti-acetylated alpha tubulin (Sigma), 1:1000 rabbit anti-
arl13b (source Bioscience), or 1:500 goat anti-hsp27 (Santa Cruz
sc-1048) were conducted at 4 °C for at least 16 h before washing in
0.1% bovine serum albumin in phosphate buffered saline. Alexa second-
ary antibodies (Life Technologies, UK) were used at 1:500 or 1:1000,
and incubated for 1 h at room temperature. Secondary only controls
were used for image thresholding but non-specific secondary binding
was very limited. For co-localization of hsp27 an hsp27 peptide (also
Santa Cruz-sc1048p) was used for competitive binding with primary
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antibody prior to cell incubations to ensure specific binding of the pri-
mary antibody. All primary antibody binding has also been previously
confirmed to be product specific as assessed by western blot. For p65
translocation studies and for co-localization studies glass coverslip
samples were imaged using a confocal microscope (Leica SP2) with a
x63/1.05 NA objective and a pixel size of 0.1 × 0.1 μm or smaller. p65
translocation images are reconstructed maximum projection images
created using Image J software as previously described [14,15]. Confocal
slices were taken with a step size ≤0.5 μm.
2.6. Data analysis and statistics
Primary cilia prevalence was assessed from multiple fields and
multiple cell seeding preparations to avoid bias. Differences were
assessed by Chi-squared tests. Cilia length was assessed similarly but
using Mann Whitney tests as length data failed normality testing.
COX2 and iNOS expression was compared using 2-way ANOVA with
post Bonferroni testing. For other protein expressionwork comparisons
between two groups and for fold changes unpaired Student's t-tests
were used. ELISA data used two-way ANOVA with post-testing. Data
analysis and testing were all conducted in GraphPad prism5.
3. Results
3.1. Hypomorphic mutation to IFT88 inhibits the induction of COX2 and
iNOS expression in response to IL-1
We set out to determine the specific nature of the influence the
cilium exerts using the cell model that first highlighted a role for the
cilium in IL-1 signalling. The Oak Ridge Polycystic Kidney (ORPK)muta-
tion reduces cilia prevalence (Fig. 1A/B) aswe have previously reported
[14,37,42]. In the present study cilia prevalence was 10% in ORPK com-
paredwith 80% inWT, a statistically significant difference (p b 0.05, Chi
squared test n= 345 and 319 cells from 11 fields for each group, data in
Fig. 1. Interleukin-1β activation of COX2 and iNOS expression is inhibited in cells unable to elaborate the primary cilia structure as a result of dysfunctional IFT. A/B Immunofluorescent
labelling of cilia markers indicates loss of primary cilia in ORPK. Cilia inWT marked by arrows. Scale bar 10 μm. CWestern blots indicate robust increases in COX2 and iNOS observed in
WT are lost in ORPK (4 replicates for bothWT and ORPK).DQuantification of relative COX2 protein levels inWT and ORPK treatedwith IL-1β (10 ng·mL−1 for 24 h). Error bars are S.E.M.,
n = 4. E Enlargement to clarify iNOS band (lower band) used for quantification. FQuantification of relative iNOS protein levels inWT and ORPK treatedwith IL-1β (10 ng·mL−1 for 24 h).
Error bars are S.E.M., n = 4.
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supplementary material S1, Fig. A). Where primary cilia are still
observed cilia length was statistically significantly reduced in ORPK
cells comparedwithWTcells (Supplementarymaterial S1, Fig. B). Ame-
dian length of 2.2 μmwas measured in WT, 1.0 μm in ORPK (p b 0.001,
MannWhitney U test, n= N200 cilia per group). The induction of COX2
and iNOS was assessed at the protein level in WT and ORPK cells in
order to establish whether the cilium regulates upstream signalling,
gene/protein induction or enzyme activity. After 24 h treatment with
IL-1β (10 ng·mL−1) WT cells exhibited statistically significant up-
regulations of both COX2 and iNOS protein levels (p b 0.0001, 2-way
ANOVA, n = 4, Fig. 1C/D/F). In stark contrast ORPK cells showed no
such large increases in COX2 or iNOS, such that treatment with IL-1β
had no statistically significant effect on either protein levels (2-way
ANOVA, n = 4, Fig. 1C/D/F). COX2 and iNOS protein levels in ORPK
cells treated with IL-1β were statistically significantly different to that
in WT also treated with IL-1β (p = b0.0001, 2-way ANOVA, n = 4).
This concurs with our previous data for the enzyme products, PGE2
and NO [14].
3.2. Loss of the primary cilium is associated with altered NFκB p65
translocation to the nucleus
One prominent signalling cascade upstream of the induction of
COX2 and iNOS is the NFκB cascade, defined largely by the translocation
of the p65 transcription factor subunit from the cytoplasm to the
nucleus. From immunofluorescent (IF) imaging of NFκB p65 in WT
cells it was clear that translocation of p65 took place within 5 min of
IL-1β treatment and was established after 20 min (Fig. 2A). Comparing
ORPKwithWT cells no apparent differenceswere seen before IL-1 treat-
ment (Supplementary material S2). However, it appeared that nuclear
translocation of the p65 subunit was delayed from initiation in ORPK.
After 5 min of IL-1 treatment, ORPK cells displayed limited nuclear in-
tensity (Fig. 2B, top panels). Nuclear intensity was reduced at 20 min
in ORPK, compared with WT (Fig. 2B, bottom panels). To quantify
total and compartmentalized protein expression western blotting was
used. It was apparent that baseline total p65 expression levels were
higher in ORPK cells than WT but expression was also highly varied in
ORPK (p = 0.18, unpaired Student's t-test, n = 6, Fig. 2C). Expression
was highly varied in ORPK (coefficient of variation 107% compared
with 29% in WT cells). Nuclear fractions were assessed for p65 protein
in control preparations and following 20 min IL-1β exposure. Whilst
statistically significant enrichment of the nuclear fraction was observed
inWT (p= 0.025, unpaired Student's t-test, n= 7) no such statistically
significant changewas seen in ORPK, in concordwith observations from
IF (Fig. 2D). The transcript binding capability of p65 protein in these
nuclear fractions was assessed by means of an enzyme linked competi-
tive binding assay using a plate coated with DNA response element for
p65. This indicated reduced transcript binding capability in lysates
from ORPK treated for 20 min with IL-1β with respect to those from
WT cells (p = 0.045, 2-way ANOVA, n = 6). Taken together this data
Fig. 2. The translocation and transcript binding ofNFκB p65 subunit is inhibited in cells unable to elaborate the primary cilia structure.A Immunofluorescent labelling of p65 subunit inWT
cells treated with IL-1β for stated periods of time. Scale bar 50 μm. B Lower power microscopy images of immunofluorescent labelling of p65 subunit inWT cells and ORPK cells treated
with IL-1β for stated periods of time. Scale bar 150 μm. CWestern blot analysis of total p65 expression relative to β-actin in WT and ORPK cells (no IL-1β treatment). D Relative nuclear
expression of p65 normalized to lamin C expression. Expression levels shown as fold increases with 20 min IL-1β (10 ng·mL−1) compared with control. E Relative p65 DNA transcript
binding for nuclear fractions isolated fromWT and ORPK cells before and after 20 min IL-1β (10 ng·mL−1). For all quantifications shown, error bars are S.E.M.
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implies that loss of the cilium is associated with diminished NFκB p65
translocation to the nucleus and DNAbinding at like for like time points.
3.3. The primary cilium influences IKK-mediated phosphorylation of IκBα
and its subsequent destruction
NFκB p65 is held in the cytoplasmby binding to inhibitor of κB (IκB).
The key events regulating the release of the p65 subunitwere assessed by
western blots at appropriate time points. Following IL-1 pathway activa-
tion the IκBαmolecule is phosphorylated, prior to its ubiquitination and
proteosomal destruction. This phosphorylation event is carried out by in-
hibitor of kappa kinase or IKKwhich itself is activated by phosphorylation
as a result of upstream signalling events. In WT cells this activating
phosphorylation of IKK was observed at 10 min post IL-1 exposure by
western blot using an antibody that recognizes serine phosphorylations
to the activation loops of both catalytic subunits of IKK namely α and β
(Fig. 3A). In ORPK this event is unaffected. No phosphorylation of IKK
was observed at later time points in either WT or ORPK cells. Expression
of phosphorylated IKKwith IL-1 treatment is not significantly different in
WT and ORPK (Fig. 3B).
In contrast, IKK activity, as assessed by western blot analysis of pIkB,
is diminished in ORPK (Fig. 4A, top blot) such that phosphorylation of
IκBα at 10 min is statistically significantly reduced (p b 0.001, 2-way
ANOVA, n = 3) with respect to WT, as quantified in Fig. 4B. The degra-
dation of IκB from 10 min onwards (Fig. 4A, second blot down) is in-
complete in ORPK with respect to WT cells such that even by 30 min
IκBα expression remains in ORPK cells. Indeed when IκBα expression
is quantified there was no statistically significant reduction in expres-
sion compared to control preparations prior to IL-1 treatment in
ORPK cells (Fig. 4C). Importantly, whilst control expression levels var-
ied, as seen for p65, there was no statistically significant difference
in IκBα amounts between WT and ORPK cells before IL-1 treatment
(Supplementary material S3). These data indicate the cilium to be
important specifically to IKK activity and downstream Iκβ degradation.
Upstream receptor and cytosolic signalling is unaffected by loss of the
cilium.
3.4. Immunofluorescence confocal imaging reveals ciliary localization of
IKK regulator, hsp27
The primary cilium conventionally regulates cell signalling bymeans
of trafficking key components through the ciliary compartment or into
the ciliary membrane. This includes receptors, molecules involved in
receptor activation, molecules key to the downstream transduction of
signalling, and transcription factors. We therefore investigated the
location of signalling molecules involved in this part of the pathway
by immunofluorescent staining (IF). WT cells were used for western
blotting, both in control experiments but at all the time points of IL-1
treatment and earlier time points such as 1, 3 and 5 min after IL-1
treatment. Previously, IκBα has been found to associate with the
microtubular organizing centre [43]. In this study it was throughout
the cell (Fig. 5A) (including sometimes on the cilium (Fig. 5A enlarged
panel)), although not clearly enough to be considered enriched above
that of the general cytosolic compartment and therefore confidently
attributed to the ciliary compartment. From translocation studies no
clear evidence for ciliary enrichment of p65 was observed. pIKK
expression was difficult to observe by IF presumably due to low
amounts but in samples treated with IL-1β at timepoints from 3 to
5 min, apparent weak pIKK staining was observed. In about 15% of
cells this staining was co-localized to the base of the cilium (Fig. 5B).
Previously, the primary cilium has been linked to the regulation of ex-
pression of the chaperone hsp27 [44], observed in motile cilia [45] and
proposed to be directly influential over IKK associated signalling events,
including by direct interaction [31–35]. We find hsp27 expression to be
highly enriched in the ciliumabove cytoplasmic levels. Stainingwas also
co-localized with the cilia localized GTPase arl13b (Fig. 5C/D), although
not when arl13b was elsewhere in the cell. In a few cases (b5%) appar-
ent cilia localized hsp27 staining was not intense or homogenous
through the axoneme (Supplementary material S4). In this example
hsp27 staining is more clearly observed throughout the rest of the
Fig. 3. Loss of cilium has no effect on IKK activation. A Example blot for pIKK expression in
WT and ORPK cells treated with IL-1β (10 ng·mL−1) for 10 min. B Quantification of pIKK
expression relative to β-actin. Data is presented as S.E.M., n = 3.
Fig. 4. IKK activity and IκBα destruction are diminished with loss of the primary cilium.
Example western blots and quantifications of key signalling events assessed during the
activation of IL-1β signalling at time points following the addition of IL-1β (10 ng·mL−1).
A. Expression of pIκBα, total IκBα, and β-actin was assessed in control and at 10, 20 and
30 min time points. B Quantification of pIκBα expression relative to β-actin. C Quantifica-
tion of IκBα expression with time after IL-1β treatment is also normalized to β-actin. For
all quantifications and S.E.M. are shown, n = ≥3.
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cytoplasmbut hsp27 stainingwas always observed in the cytoplasmwhen
3Dmaximumprojections of the cells were created (Fig. 5D).When cellular
expression of hsp27was compared betweenWT and ORPK cells hsp27 ex-
pression was predictably very low inWT, such that the band is barely vis-
ible when compared with the markedly higher expression in ORPK
(Fig. 5E). Likewisewhen the phosphorylation of hsp27with IL-1 treatment
was assessed this was only observable in western blot in the ORPK cells
(Supplementary S5). It was not possible to image phsp27 by IF.
4. Discussion
This study develops previous findings describing loss of responses to
IL-1β in cells where primary cilia trafficking is impaired [14]. Previously,
we did not observe normal increases in the inflammatorymarkers PGE2
and NO in cells where IFT was impaired. This implied that the ciliary
compartment is required for these inflammatory responses. In the
present study we show that these findings were likely due to primary
cilia influence over the magnitude and timing of upstream NFκB
pathway signalling events.
Whilst the primary ciliumhaswell-established roles in the regulation
ofmany signallingpathways, beyond our previous study of 2012, there is
little to link the cilium to the regulation of IL-1β signalling. However, low
NOhas been a clinicalmarker for some time in a human genetic disorder,
primary ciliary dyskinesia. This disorder relates to dysfunction of motile
cilia, which share much structural homology with primary cilia. In addi-
tion there is evidence that cells isolated from these patients have a
reduced capacity to respond to infectious challenge [46]. Moreover,
very recently, human disorders related to primary cilia dysfunction, in-
cluding Jeune syndrome [47] and short rib polydactyly (SRP) syndrome
type III [48] have been linked to WDR34, already linked to NFκB signal-
ling [49]. Recent studies have linked NFκB signalling components to
motile [50] ciliogenesis and primary cilia disassembly in stem cells [51].
Our present study indicates that the cilium exerts influence at the
bottleneck in the NFκB signalling cascade. Loss of the cilium influences
events after early receptor-linked events but before protein induction
and activation. PGE2 and NO are products of the induction of the
phospholipid-modifying enzyme PGES and iNOS respectively. In the
case of PGE2, COX2 is the rate-limiting enzyme induced. Removal of
the cilium inhibits IL-1-induced expression of COX2 and iNOS, in accor-
dance with a failure of upstream signalling, rather than deregulated
transcription. Membrane located, receptor-linked signalling and imme-
diate pathway activation appears unaffected by loss of the cilium but
cannot be ruled out. IKK subunit phosphorylation, governed by the
activities of TAK1, was not significantly altered in ORPK cells. This is
also supported by the observation of IL-1-induced phosphorylation of
hsp27 in ORPK cells as this is also downstream of TAK1 activities albeit
Fig. 5. IKK regulator hsp27 is enriched in the primary cilium. A Immunofluorescent (IF) labelling indicates possible cilia localization of IκBα as indicated by arrow, at 10 min after IL-1β
treatment. However, staining in cilium was no higher than prevalent staining in the wider cytoplasm. Scale bar in enlargement is 2.5 μm. B Example of basal body localization of pIKK
staining, also indicated with arrow. Scale bar is 2.5 μm. C IF labelling shows striking co-localisation of hsp27 to arl13b staining in the primary cilium. Images from single confocal slice.
DMaximum Z projection shows majority, but not all hsp27 signal in primary cilia. EWestern blot analysis of total hsp27 indicates far greater levels of hsp27 in ORPK cells such that
hsp27 and phsp27 expression is barely detectable by western blot.
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via p38 pathway activation. The focus therefore moved to the activities
of cytoplasmic IκB, which exerts inhibitory influence by holding the
NFκB transcription subunit p65 away from the nucleus.
The cilium and its trafficking appear to be critical specifically to the
phosphorylation of IκB by IKK, and therefore subsequent IκB destruction
which is dependent upon this IKK activity. When the cilium is lost IκB
levels are abnormally sustained, where expression is quickly abolished
in WT cells. There is, predictably, strong concord between these data
and downstreamp65 nuclear translocation. Nuclear p65when assessed
qualitatively by immunofluorescent staining following IL-1 exposure,
was still observed, even with loss of the cilium, but is diminished in
magnitude and appears delayed. This is to be expected, given the
sustained expression of IκB. This was supported by analysis of nuclear
fractions quantifying p65 levels andDNAbinding capacity. These inhibi-
tions are not of such dramatic magnitude as those seen ultimately
downstream at the level of iNOS, COX2 and their products, implying a
few possibilities. One, that the cilium also exerts wider influence over
other components of IL-1 signalling including p38 MAP kinases — this
is the subject of a current, ongoing separate study. Secondly, it's is also
important to note that the population of ORPK cells still assemble
basal bodies, and 1 in 10 elaborates primary cilia, albeit stunted in
nature. Finally, the perceived incomplete inhibition of IKK activity, p65
translocation and transcript binding may reflect a subtle, but vital,
tuning role for the primary cilium. The cilium may govern the timing
of these events and as such downstream this influence maymaterialize
to a greater extent. The timing of NFκB signalling is of fundamental
importance to downstream pathway activity [52] and specificity
[53,54]. Aberrant pathway status and deregulated feedback on the path-
waymay underlie the large variation of baseline p65 and IκB expression
in ORPK cells. All these data agree on multiple levels that the primary
cilia compartment and its trafficking are of importance to and exert
influence over NFκB signalling.
Previous studies have indicated alterations to primary cilia traffick-
ing and contents during the activation of IL-1β signalling [14,42]. With
this in mind we checked for the ciliary localization of the molecular
components of the pathway. Despite broad cytoplasmic expression,
we did find incidences of apparent but weak IκBα staining in the cilium.
It must be said that this was not above the cytosolic levels and as such
it's hard by microscopy alone to be certain of the ciliary localization of
such protein. Predictably, even with IL-1 treatment, phosphorylated
IKK staining was of low intensity but there was apparent ciliary base
staining for this activated form of IKK, albeit weak. Therefore is again
difficult to, with certainly, conclude that ciliary trafficking is taking
place in response to IL-1. This will require further work and high resolu-
tion microscopy. The heat shock proteins function as chaperones to aid
protein–protein interactions through protein folding. One such chaper-
one, hsp27, has been observed inmotile cilia [45] and hsp27 expression
is linked to that of the ciliary protein IFT88 [44]. Hsp27 has also been
illustrated to both positively and negatively regulate NFκB signalling
through interactions throughout the signalling cascade.More specifically,
hsp27 and IKK are physical binding partners [55] and hsp27 directly
alters IKK activity, although there is conflict, likely cell type specific, as
to whether it plays a promotional or inhibitory role [31–35,56]. In the
current study we find highly enriched hsp27 expression in the primary
cilium, co-localized to the ciliary trafficking coordinator arl13b. We
tentatively propose the cilia compartment to be a location for the highly
regulated and precisely timed molecular interactions NFκB signal trans-
duction requires, and that the presence of the chaperone hsp27 may
underpin themolecular mechanism for this in NFκB signalling. The alter-
ation to hsp27 location and total levels, as a result of dysfunctional
ciliogenesis, may be the cause for inhibited NFκB signalling and down-
stream cellular responsiveness. These studies both illuminate the cilium's
role and define the specificmolecular eventswhich the ciliumpotentially
houses and thereby governs. This is summarized within the context of a
highly simplified signalling cascade in Fig. 6, with events that are ciliary
regulated in red.
The primary cilium is an ever-emerging exciting location for
signalling cross-talk. It activities thereby influence the development,
physiology and pathology of many tissues. In cartilage, mechanical
and inflammatory cues drive arthritis. Interestingly, both cues alter
primary cilia length [14,57], function and down-regulate IKK activities
[58]. This may represent an anti-pathological feedback mechanism.
This is of high relevance not only to cartilage but also in much wider
contexts including cancers, where inflammatory and mechanical cues
mediate pathology. Cilia localized heat shock proteins such as hsp27
have established roles in inflammatory signalling in chondrocytes
[59,60] and hsp27 expression is altered in OA [61]. Hsp27 is a putative
clinical marker in cancers [62–64]. Intriguingly hypoxia inducible factor
2 (HIF2), hugely influential to cell physiology and pathology is also
known to bind and regulate IKK [65]. Recently, we have shown HIF2
to traffic through the cilium possibly in order to target its regulated de-
struction [42]. Many biochemical signals, for example increased cAMP,
regulate ciliary trafficking and thereby structure and function [17] and
also block downstream targets of inflammatory signalling [66]. This
Fig. 6.A simplified signalling schematic to show proposed eventswhere the cilium is proposed to regulate (highlighted in red). In the absence of IL-1, IκB traps p65 in the cytoplasm. In the
presence of IL-1, receptor related events lead to the activation (phosphorylation as denoted by small black p) of IKK. These events are not dependent upon the ciliary compartment, as
indicated by data in Fig. 3. However, the primary cilium may represent a critical location for, even scaffold upon which, the key molecular interactions between activated IKK and IκB,
leading to IκB destruction, take place (as indicated by the data in Fig. 4). These events allow NFκB p65 release to the nucleus and are mistimed or diminished in magnitude without
the cilium (as indicated by the data in Fig. 2). Ciliary trafficking of IKK and IκB to interact with ciliary hsp27 (Fig. 5) may allow controlled and rapid phosphorylation of IκB and its subse-
quent destruction, releasing a burst of p65 transcription factor to bind to transcriptional targets such as iNOS and COX2. In the absence of functional IFT88 cilia trafficking (ORPK) the delay
or reduction in magnitude of these events results in a failure to induce target (Fig. 1).
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strengthens the possibility that targeting cilia architecture may provide
clinically useful modulation of cell behaviour by tuning the molecular
events taking place on the cilium.
5. Conclusions
To conclude, this study reveals the mechanism for how the primary
cilium influences inflammatory signalling, for the first time highlighting
an influence over NFκB signalling and at the level of IKK activity. IKK and
NFκB are influential in biological contexts spanning differentiation to
disease. The specialized and therefore the potentially targetable primary
cilia structure and machinery are now of worthy investigation in con-
texts where therapeutic regulation of IKK or NFκB signalling is sought.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.cellsig.2014.04.004.
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